A Study of Inhaled AZD8630 in Adolescents With Asthma
Status:
RECRUITING
Trial end date:
2026-02-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, tolerability, and immunogenicity of single inhaled dose of AZD8630 administered in adolescent participants with asthma as well as the safety and performance of the dry powder inhaler.